Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
Colorectal cancer (CRC) is one of the intimidating causes of death around the world. CRC originated from mutations of tumor suppressor genes, proto-oncogenes and DNA repair genes. Though platinum (Pt)-based anticancer drugs have been widely used in the treatment of cancer, their toxicity and CRC cel...
Saved in:
Main Authors: | Kazi Mustafa Mahmud (Author), Mahruba Sultana Niloy (Author), Md Salman Shakil (Author), Md Asiful Islam (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy
by: Cheng Zhang, et al.
Published: (2022) -
Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs
by: Catarina Teixeira-Guedes, et al.
Published: (2022) -
New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential
by: Ana Rita Brás, et al.
Published: (2023) -
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
by: Ke Lin, et al.
Published: (2018) -
Biological Activities of Ruthenium NHC Complexes: An Update
by: Alessia Catalano, et al.
Published: (2023)